NovaBay Pharmaceuticals Inc
F:B9P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NovaBay Pharmaceuticals Inc
F:B9P
|
US |
|
Bayerische Motoren Werke AG
OTC:BYMOF
|
DE |
|
W
|
Williams Companies Inc
XBER:WMB
|
US |
|
C
|
COSCO Shipping Energy Transportation Co Ltd
XMUN:HIFH
|
CN |
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
China Everbright Bank Co Ltd
HKEX:6818
|
CN |
|
K
|
KGHM Polska Miedz SA
F:KGHA
|
PL |
|
S
|
Sogefi SpA
MIL:SGF
|
IT |
|
C
|
Carnival PLC
SWB:POH1
|
UK |
|
P
|
Pulsar Helium Inc
OTC:PSRHF
|
CA |
|
H
|
Hochtief AG
XBER:HOT
|
DE |
|
A
|
Argo Blockchain PLC
NASDAQ:ARBK
|
UK |
|
A
|
Arrow Electronics Inc
XMUN:ARW
|
US |
|
J
|
J.Front Retailing Co Ltd
TSE:3086
|
JP |
|
Inmode Ltd
NASDAQ:INMD
|
IL |
|
I
|
Itron Inc
DUS:IT6
|
US |
|
Mcphy Energy SA
PAR:ALMCP
|
FR |
|
L
|
Lam Research Corp
XBER:LAR
|
US |
|
A
|
Abirami Financial Services (India) Ltd
BSE:511756
|
IN |
|
NexPoint Residential Trust Inc
F:5O4
|
US |
|
Subsea 7 SA
OSE:SUBC
|
UK |
|
Radian Group Inc
NYSE:RDN
|
US |
|
Leonteq AG
F:EFL
|
CH |
|
M
|
Medical Properties Trust Inc
SWB:M3P
|
US |
Discount Rate
B9P Cost of Equity
Discount Rate
B9P's Cost of Equity, calculated using the formula Risk-Free Rate + Beta x ERP, stands at 8.43%. The Beta, indicating the stock's volatility relative to the market, is 0.96, while the current Risk-Free Rate, based on government bond yields, is 4.42%, and the ERP, measuring the extra return over the risk-free rate required by investors, is 4.18%.
B9P WACC
Discount Rate
B9P's Weighted Average Cost of Capital (WACC) is calculated as the weighted average of its cost of equity and cost of debt, adjusted for tax. The WACC stands at 8.43%. This includes the cost of equity at 8.43%, calculated as Risk-Free Rate + Beta x ERP, and the cost of debt at 9.02%, reflecting the interest rate on B9P's debt adjusted for tax benefits. The weight of debt in the capital structure is 0.21%.
What is B9P's discount rate?
B9P's current Cost of Equity is 8.43%, while its WACC stands at 8.43%. The selection of the appropriate discount rate is contingent on the type of cash flows being discounted.
For Equity Valuation: When valuing equity, especially in scenarios where you are discounting cash flows to equity holders (such as Net Income, Earnings Per Share (EPS), or Free Cash Flow to Equity), the Cost of Equity should be used.
For Firm Valuation: In contrast, when valuing the entire firm and discounting cash flows available to both debt and equity holders (like Free Cash Flow to the Firm), the Weighted Average Cost of Capital (WACC) is the appropriate rate.
How is Cost of Equity for B9P calculated?
The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP).
This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk.
Here is how we calculate the cost of equity for B9P
How is WACC for B9P calculated?
WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company’s entire operations.
The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure.
Here is how we calculate WACC for B9P
